earnings and But offset progress And with discuss detail Thanks, operational everyone this our planned I'll operations. our fourth and than reimbursement us and outstanding we results, helped for then the by from quarter record ended cash the on solid then strategy us of a our revenues, strategy. volume year excellence execution on had review guidance. fourth combined expanded pressure. through growth the today. Strong access, network health Shawn, significant from morning two-point XXXX Mark delivering will quarter more Well, joining thanks and provide you take
the and X.X%, at period we reported same X.X%. strong nearly quarter, adjusted in from XX% grew $X.XX fourth the was Volume XXXX. remained $X.XX, For growth up EPS was EPS revenues
and volume of adjusted full grew grew X.X%, $X.XX XXXX, reported and X.X%. $X.XX revenues EPS grew X% XX% the to to grew year For EPS
In quarterly And the dividend increasing our since this nearly XXXX. are is by increase addition, we X%. ninth
the to AAA, the into well of PAMA Quest details the like getting of healthcare's on as within and Act. is LAB covered quarter, passage fourth recent I'd as the more how Before discuss squarely
within focusing quality many the while which reducing patient is improving So cost are healthcare's about on healthcare all AAA, and the providers of care. medical experience,
UnitedHealthcare's example is Quest we become One drive a quality to provide our and network. input We're our that of us performance quality. is pickups. quality six dedicated lab medical by tracking service enables to preferred great logistics specimen in proud member a that
past the Walmart great in our in centers, Also years services. our the made service is Score as health such as drive are on which care and XX%. satisfaction several very high to helping Safeway as scores over and strides above retailers patient improving partnerships Promoter we've exceeds Second, Investments our digital patient XX%, well Net with patient experience. platforms particularly
Finally, higher boutiques Quest to Test even prices more. lab offers than the hospital smaller two of our and and many best competitors five be the value prices industry. can times our sometimes for in
patient none quality, delivers proposition second a industry. is that competitive in experience medical together, So to and our taken pricing our value
I'd like Quest. favor three fundamental you the marketplace, I which changes to update to on believe
the reimbursement industry in largest is this has seen. This PAMA. hub First, Medicare ever
with focusing providers. plans looking are health receive And opportunities variation care at Second, value for they fewer on delivery. higher wide in work price the health to
the with of implementation and access lab of examples preferred are the UnitedHealthcare expanded perfect network Our this. network
Diagnostics deal and the is care value. more town. is the increasing in more of Consumers We And consumerization looking health shouldering of believe care. then best and they're are best cost of for third the health the Quest
of it become development first and the to Act. December. fixing the LAB CMS's We PAMA delay will on collection to is LAB data regarding will comment Lab Act And period the identify quickly that as to for were see quarter initially first market the step the pleased The one-year collect way rates Congress deeply Act data in reflects also reporting through It private of like the I'd a require intended. the better XXXX. the data to process. in MedPAC latest passage to late law
in know expect As XXXX. caps to many be fee PAMA of Despite basis relatively CMS reimbursement headwinds the reduction delay increase XXXX. to in and will that with for you cuts the from the in now one-year XXXX on the in the schedule in existing XXXX, means XX% we XXXX consistent XXXX delay XX% of
HHS. the sides hands continues its to the challenge judge. of briefs their the associations submitted legal courts Both and the trade our have ACLA, in against Additionally matters
We decision expect a year. sometime this
our Now, progress. to recent performance and turning
two-point the then of finally, which hospital per broadest is offer has acquisitions; diagnostic part grow X% and consumer-friendly more analytics five accretive growth, data and health strategically access to recognizes accelerate with elements; our first services. aligned relationships services. The strategy information through And year to systems; extended health population health expand than support We're as of provider care diagnostic with innovation. the plans
a me take to from accelerate you through our growth. few strategy Now highlights let
Our acquisition pipeline remains strong.
announced Clinical Laboratories, laboratory During a regional acquisition Massachusetts. in the of fourth small Boston quarter, the we
We also announced new two recently acquisitions.
Blueprint's bioinformatics, the sequencing. in The and significantly is especially, genetics, our advanced It first, platform which leadership to Genetics. next-generation reporting specialty is of interpretation. average speed Blueprint position bottleneck diagnostics, strengthens at often proven proprietary expected interpretation and in variant rate through a time
Texas. largest Hermann also We health the one Memorial in a the System, with Southeast multifaceted not-for-profit systems of announced Health collaboration long-term
under agreement. in close As acquire hospital Greater outreach Hermann's all transaction part lab The the to manage of business Houston its services in services inpatient Memorial is will Quest of professional and second quarter. expected the lab our agreement, labs XX
signed eight professional we hospital services with health in laboratory recently an And system Tennessee. then a agreement finally,
health accelerating continue result network as revenue see access. branded We growth plan to and a of our volume
QuantiFERON out-of-pocket growth Network, growth. monitoring, for both our demonstrates sequential volumes cancer look drug of Preferred solid to full $X of and hemepath, cost blood revenue further quarter our market to The United's The these posted year growth. and IQ. continued categories featuring the in test test We contributions test the forward drive ability Cardio T-SPOT, of Each and share tuberculosis acceleration in testing members. to include rollout Lab drivers
G-based part approximately productivity We our from year, our see to for XXXX by drive Overall, increases while our reduce year to then, acceleration a X% of second esoteric in X% ago. ahead excellence. an goal And single-digit to low to delivered more the productivity. the two-point cost and on testing our customer drive base grew by experience. further operational growth our strategy drive enhancing We continuing gains, opportunities is
examples. three here's So
more consolidation approximately $XX us throughput, annually while and immunoassay First, saving our when platform efficient brief footprint, is to expected implemented. million fully provide autonomy
in Second, our provide we consolidate in Jersey. new to flagship laboratory throughput capacity. regional is expected more our lab labs, in lab our optimizing are and XX% network New operationally hub double average investments active Clifton, When three through our XXXX, new
to receive we're Nearly make And technology enhance customer digital results. their platform, million the then enables the downloaded them nine appointments using patients to have third, digital and experience. which MyQuest
Now Mark through to it over to let Mark? me turn go the results.